Cargando…
Assessment of Enterovirus Excretion and Identification of VDPVs in Patients with Primary Immunodeficiency in India: Outcome of ICMR–WHO Collaborative Study Phase-I
The emergence of vaccine-derived polioviruses (VDPVs) in patients with Primary Immunodeficiency (PID) is a threat to the polio-eradication program. In a first of its kind pilot study for successful screening and identification of VDPV excretion among patients with PID in India, enteroviruses were as...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383878/ https://www.ncbi.nlm.nih.gov/pubmed/37515027 http://dx.doi.org/10.3390/vaccines11071211 |
_version_ | 1785081019210137600 |
---|---|
author | Mohanty, Madhu Chhanda Desai, Mukesh Mohammad, Ahmad Aggarwal, Amita Govindaraj, Geeta Bhattad, Sagar Lashkari, Harsha Prasada Rajasekhar, Liza Verma, Harish Kumar, Arun Sawant, Unnati Varose, Swapnil Yashwant Taur, Prasad Yadav, Reetika Malik Tatkare, Manogat Fernandes, Mevis Bargir, Umair Majumdar, Sanjukta Edavazhippurath, Athulya Rangarajan, Jyoti Manthri, Ramesh Madkaikar, Manisha Ranjan |
author_facet | Mohanty, Madhu Chhanda Desai, Mukesh Mohammad, Ahmad Aggarwal, Amita Govindaraj, Geeta Bhattad, Sagar Lashkari, Harsha Prasada Rajasekhar, Liza Verma, Harish Kumar, Arun Sawant, Unnati Varose, Swapnil Yashwant Taur, Prasad Yadav, Reetika Malik Tatkare, Manogat Fernandes, Mevis Bargir, Umair Majumdar, Sanjukta Edavazhippurath, Athulya Rangarajan, Jyoti Manthri, Ramesh Madkaikar, Manisha Ranjan |
author_sort | Mohanty, Madhu Chhanda |
collection | PubMed |
description | The emergence of vaccine-derived polioviruses (VDPVs) in patients with Primary Immunodeficiency (PID) is a threat to the polio-eradication program. In a first of its kind pilot study for successful screening and identification of VDPV excretion among patients with PID in India, enteroviruses were assessed in stool specimens of 154 PID patients across India in a period of two years. A total of 21.42% of patients were tested positive for enteroviruses, 2.59% tested positive for polioviruses (PV), whereas 18.83% of patients were positive for non-polio enteroviruses (NPEV). A male child of 3 years and 6 months of age diagnosed with Hyper IgM syndrome was detected positive for type1 VDPV (iVDPV1) with 1.6% nucleotide divergence from the parent Sabin strain. E21 (19.4%), E14 (9%), E11 (9%), E16 (7.5%), and CVA2 (7.5%) were the five most frequently observed NPEV types in PID patients. Patients with combined immunodeficiency were at a higher risk for enterovirus infection as compared to antibody deficiency. The high susceptibility of PID patients to enterovirus infection emphasizes the need for enhanced surveillance of these patients until the use of OPV is stopped. The expansion of PID surveillance and integration with a national program will facilitate early detection and follow-up of iVDPV excretion to mitigate the risk for iVDPV spread. |
format | Online Article Text |
id | pubmed-10383878 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103838782023-07-30 Assessment of Enterovirus Excretion and Identification of VDPVs in Patients with Primary Immunodeficiency in India: Outcome of ICMR–WHO Collaborative Study Phase-I Mohanty, Madhu Chhanda Desai, Mukesh Mohammad, Ahmad Aggarwal, Amita Govindaraj, Geeta Bhattad, Sagar Lashkari, Harsha Prasada Rajasekhar, Liza Verma, Harish Kumar, Arun Sawant, Unnati Varose, Swapnil Yashwant Taur, Prasad Yadav, Reetika Malik Tatkare, Manogat Fernandes, Mevis Bargir, Umair Majumdar, Sanjukta Edavazhippurath, Athulya Rangarajan, Jyoti Manthri, Ramesh Madkaikar, Manisha Ranjan Vaccines (Basel) Article The emergence of vaccine-derived polioviruses (VDPVs) in patients with Primary Immunodeficiency (PID) is a threat to the polio-eradication program. In a first of its kind pilot study for successful screening and identification of VDPV excretion among patients with PID in India, enteroviruses were assessed in stool specimens of 154 PID patients across India in a period of two years. A total of 21.42% of patients were tested positive for enteroviruses, 2.59% tested positive for polioviruses (PV), whereas 18.83% of patients were positive for non-polio enteroviruses (NPEV). A male child of 3 years and 6 months of age diagnosed with Hyper IgM syndrome was detected positive for type1 VDPV (iVDPV1) with 1.6% nucleotide divergence from the parent Sabin strain. E21 (19.4%), E14 (9%), E11 (9%), E16 (7.5%), and CVA2 (7.5%) were the five most frequently observed NPEV types in PID patients. Patients with combined immunodeficiency were at a higher risk for enterovirus infection as compared to antibody deficiency. The high susceptibility of PID patients to enterovirus infection emphasizes the need for enhanced surveillance of these patients until the use of OPV is stopped. The expansion of PID surveillance and integration with a national program will facilitate early detection and follow-up of iVDPV excretion to mitigate the risk for iVDPV spread. MDPI 2023-07-06 /pmc/articles/PMC10383878/ /pubmed/37515027 http://dx.doi.org/10.3390/vaccines11071211 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Mohanty, Madhu Chhanda Desai, Mukesh Mohammad, Ahmad Aggarwal, Amita Govindaraj, Geeta Bhattad, Sagar Lashkari, Harsha Prasada Rajasekhar, Liza Verma, Harish Kumar, Arun Sawant, Unnati Varose, Swapnil Yashwant Taur, Prasad Yadav, Reetika Malik Tatkare, Manogat Fernandes, Mevis Bargir, Umair Majumdar, Sanjukta Edavazhippurath, Athulya Rangarajan, Jyoti Manthri, Ramesh Madkaikar, Manisha Ranjan Assessment of Enterovirus Excretion and Identification of VDPVs in Patients with Primary Immunodeficiency in India: Outcome of ICMR–WHO Collaborative Study Phase-I |
title | Assessment of Enterovirus Excretion and Identification of VDPVs in Patients with Primary Immunodeficiency in India: Outcome of ICMR–WHO Collaborative Study Phase-I |
title_full | Assessment of Enterovirus Excretion and Identification of VDPVs in Patients with Primary Immunodeficiency in India: Outcome of ICMR–WHO Collaborative Study Phase-I |
title_fullStr | Assessment of Enterovirus Excretion and Identification of VDPVs in Patients with Primary Immunodeficiency in India: Outcome of ICMR–WHO Collaborative Study Phase-I |
title_full_unstemmed | Assessment of Enterovirus Excretion and Identification of VDPVs in Patients with Primary Immunodeficiency in India: Outcome of ICMR–WHO Collaborative Study Phase-I |
title_short | Assessment of Enterovirus Excretion and Identification of VDPVs in Patients with Primary Immunodeficiency in India: Outcome of ICMR–WHO Collaborative Study Phase-I |
title_sort | assessment of enterovirus excretion and identification of vdpvs in patients with primary immunodeficiency in india: outcome of icmr–who collaborative study phase-i |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383878/ https://www.ncbi.nlm.nih.gov/pubmed/37515027 http://dx.doi.org/10.3390/vaccines11071211 |
work_keys_str_mv | AT mohantymadhuchhanda assessmentofenterovirusexcretionandidentificationofvdpvsinpatientswithprimaryimmunodeficiencyinindiaoutcomeoficmrwhocollaborativestudyphasei AT desaimukesh assessmentofenterovirusexcretionandidentificationofvdpvsinpatientswithprimaryimmunodeficiencyinindiaoutcomeoficmrwhocollaborativestudyphasei AT mohammadahmad assessmentofenterovirusexcretionandidentificationofvdpvsinpatientswithprimaryimmunodeficiencyinindiaoutcomeoficmrwhocollaborativestudyphasei AT aggarwalamita assessmentofenterovirusexcretionandidentificationofvdpvsinpatientswithprimaryimmunodeficiencyinindiaoutcomeoficmrwhocollaborativestudyphasei AT govindarajgeeta assessmentofenterovirusexcretionandidentificationofvdpvsinpatientswithprimaryimmunodeficiencyinindiaoutcomeoficmrwhocollaborativestudyphasei AT bhattadsagar assessmentofenterovirusexcretionandidentificationofvdpvsinpatientswithprimaryimmunodeficiencyinindiaoutcomeoficmrwhocollaborativestudyphasei AT lashkariharshaprasada assessmentofenterovirusexcretionandidentificationofvdpvsinpatientswithprimaryimmunodeficiencyinindiaoutcomeoficmrwhocollaborativestudyphasei AT rajasekharliza assessmentofenterovirusexcretionandidentificationofvdpvsinpatientswithprimaryimmunodeficiencyinindiaoutcomeoficmrwhocollaborativestudyphasei AT vermaharish assessmentofenterovirusexcretionandidentificationofvdpvsinpatientswithprimaryimmunodeficiencyinindiaoutcomeoficmrwhocollaborativestudyphasei AT kumararun assessmentofenterovirusexcretionandidentificationofvdpvsinpatientswithprimaryimmunodeficiencyinindiaoutcomeoficmrwhocollaborativestudyphasei AT sawantunnati assessmentofenterovirusexcretionandidentificationofvdpvsinpatientswithprimaryimmunodeficiencyinindiaoutcomeoficmrwhocollaborativestudyphasei AT varoseswapnilyashwant assessmentofenterovirusexcretionandidentificationofvdpvsinpatientswithprimaryimmunodeficiencyinindiaoutcomeoficmrwhocollaborativestudyphasei AT taurprasad assessmentofenterovirusexcretionandidentificationofvdpvsinpatientswithprimaryimmunodeficiencyinindiaoutcomeoficmrwhocollaborativestudyphasei AT yadavreetikamalik assessmentofenterovirusexcretionandidentificationofvdpvsinpatientswithprimaryimmunodeficiencyinindiaoutcomeoficmrwhocollaborativestudyphasei AT tatkaremanogat assessmentofenterovirusexcretionandidentificationofvdpvsinpatientswithprimaryimmunodeficiencyinindiaoutcomeoficmrwhocollaborativestudyphasei AT fernandesmevis assessmentofenterovirusexcretionandidentificationofvdpvsinpatientswithprimaryimmunodeficiencyinindiaoutcomeoficmrwhocollaborativestudyphasei AT bargirumair assessmentofenterovirusexcretionandidentificationofvdpvsinpatientswithprimaryimmunodeficiencyinindiaoutcomeoficmrwhocollaborativestudyphasei AT majumdarsanjukta assessmentofenterovirusexcretionandidentificationofvdpvsinpatientswithprimaryimmunodeficiencyinindiaoutcomeoficmrwhocollaborativestudyphasei AT edavazhippurathathulya assessmentofenterovirusexcretionandidentificationofvdpvsinpatientswithprimaryimmunodeficiencyinindiaoutcomeoficmrwhocollaborativestudyphasei AT rangarajanjyoti assessmentofenterovirusexcretionandidentificationofvdpvsinpatientswithprimaryimmunodeficiencyinindiaoutcomeoficmrwhocollaborativestudyphasei AT manthriramesh assessmentofenterovirusexcretionandidentificationofvdpvsinpatientswithprimaryimmunodeficiencyinindiaoutcomeoficmrwhocollaborativestudyphasei AT madkaikarmanisharanjan assessmentofenterovirusexcretionandidentificationofvdpvsinpatientswithprimaryimmunodeficiencyinindiaoutcomeoficmrwhocollaborativestudyphasei |